Skip to content
Open access

Long-Term Survival and Maturation of Transplanted Cerebral Organoids Derived from Human Induced Pluripotent Stem Cells

Aug 2026 · Cells · Vol 15, pp. 1466 · 0 citations · 38 references
Medicine

TL;DR

This study demonstrates the long-term survival and maturation of cerebral organoids derived from hiPSCs in vivo and provides evidence for the feasibility of cerebral organoids derived from hiPSCs as a potential cell transplantation therapy.

Abstract

Highlights What are the main findings? hiPSC-derived cerebral organoids survived and matured into cortical neuronal subtypes, GABAergic neurons, and glial cells at 12 months post-transplantation. Grafted cells formed synapses and achieved vascularization within the host brain. What are the implications of the main findings? This study provides evidence of the long-term survival, multilineage differentiation, and maturation of hiPSC-derived cerebral organoid grafts. Synaptic formation and vascularization between grafts and hosts provide the foundation for the clinical application of brain organoids as cell therapy resources. Abstract Human cerebral organoids have emerged as a promising new therapeutic strategy for cell transplantation after brain injury. Researchers have explored the short-term survival and maturation of human cerebral organoids derived from human embryonic stem cells (hESCs) in animal models. However, the long-term survival and maturation of cerebral organoids derived from human induced pluripotent stem cells (hiPSCs) have not been studied in depth. In this study, we generated cerebral organoids from hiPSCs in a feeder-free culture system. Then, the cerebral organoids were digested into small clusters and transplanted into the frontal cerebral cortex of postnatal day 0 (P0) SCID mice. The long-term survival and maturation of the grafted cerebral organoids were evaluated at 12 months post-transplantation. Our results indicate that grafted cerebral organoids survive well and maintain their forebrain identity in vivo over a long period. The transplanted cerebral organoids showed reduced proliferative capacity, indicating a low risk of tumor formation. The majority of transplanted cells differentiated into cortical neuronal subtypes in different cortical layers in anatomical lamination at 12 months post-transplantation. In addition, a small population of grafted cerebral organoids matured into GABAergic neurons and gliocytes, including astrocytes, microglia and oligodendrocytes. Furthermore, the grafts formed synapses with the host cells and achieved vascularization in the host brain. Our study demonstrates the long-term survival and maturation of cerebral organoids derived from hiPSCs in vivo and provides evidence for the feasibility of cerebral organoids derived from hiPSCs as a potential cell transplantation therapy.

Read PDF

Similar papers

Open access Oct 2026

Long-lasting survival, migration and functional maturation of transplanted human reprogrammed neurons in vivo.

Direct reprogramming of glial progenitor cells (GPCs) into induced neurons (iNs) represents a promising strategy for future brain regenerative therapies. This approach uses forced expression of neuronal fate-determining genes to convert non-neuronal cells into neurons, bypassing a pluripotent intermediate stage and ena...

E. Cepeda-Prado, Gianluigi Nocera, Christina-Anastasia Stamouli et al. · 0 citations
Open access Oct 2026

Organoid-to-organoid transplantation and pro-neurogenic treatment promote graft integration and neuronal repair in a human ischemic model

Neuronal loss resulting from brain injury and neurodegenerative diseases currently lacks effective regenerative therapies. While neurogenic compounds and cell transplantation hold promise, clinical translation is hindered by poor graft integration and limited cell survival. Here, we developed a novel organoid-to-organo...

Ricardo Gómez-Oliva, Sergio Helgueta, Nerea Alonso-Galeron et al. · 0 citations
#explainable ai Review Open access Sep 2026

Using Brain Organoids to Explore Human Neurobiology

The graphic presented represents a summary of the overall workflow used for creating, characterizing, and medical uses of the brain organoids derived from stem cells, and represents a detailed process of brain organoid research and its application.

H. E. Marei, Anwarul Hasan · 0 citations
Open access Sep 2026

Generation and application of human pluripotent stem cells derived peri-nervoids

Autologous nerve grafts remain the gold standard for peripheral nerve repair, but donor scarcity, donor-site morbidity and incomplete functional recovery limit their use. Schwann cells (SCs) drive autograft-mediated regeneration, yet their limited availability and expansion impede SC-based therapies. Here, we generated...

Yan-Jun Guan, Rui-Chao He, Zi-Yue Xiang et al. · 0 citations
Open access Sep 2026

Developmental xenocortication using human-derived organoids in mice

This platform establishes a transplantation platform using a genetic strategy to effectively deplete glutamatergic neurons from mouse neocortex and hippocampus and neonatally engraft the cortical cavity with human stem-cell-derived cortical organoids (hCO) to generate xenocortical mice, and envision that xenocorticatio...

Konstantin Kaganovsky, Kevin W. Kelley, T. Gschwind et al. · 5 citations
Aug 2026

PTPσ mediates the integration of grafted neuronal tissueoids with host neural pathways after complete spinal cord injury.

E engineered human iPSC-derived neuronal tissueoids (Ntoids) in vitro revealed that the PTPσ-TrkC complex may participate in synaptic integration between transplanted neurons and host circuits, constituting a structural foundation for functional neural relay restoration in spinal cord injury repair.

Rui Mao, Yuan-Huan Ma, Jinyuan Xiao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.